Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents

Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents

Katherine Ververis,1 Alison Hiong,1 Tom C Karagiannis,1,* Paul V Licciardi2,*1Epigenomic Medicine, Alfred Medical Research and Education Precinct, 2Allergy and Immune Disorders, Murdoch Childrens Research Institute, Melbourne, VIC, Australia*These authors contributed equally to this workAbstract: Hi...

Full description

Bibliographic Details
Main Authors:	Ververis K, Hiong A, Karagiannis TC, Licciardi PV
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-02-01
Series:	Biologics: Targets & Therapy
Online Access:	http://www.dovepress.com/histone-deacetylase-inhibitors-hdacis-multitargeted-anticancer-agents-a12289

Similar Items

HDACiDB: a database for histone deacetylase inhibitors
by: Murugan K, et al.
Published: (2015-04-01)

Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 inhibitors
by: Regina Martínez, et al.
Published: (2020-03-01)

Design, synthesis, molecular docking study, and biological evaluation of salicylaldimine derivatives as potential histone deacetylases inhibitors (HDACi) and anticancer agents
by: Heba M. Hesham, et al.
Published: (2018-06-01)

Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies
by: Marinella Zilli, et al.
Published: (2013-07-01)

In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi)
by: Annabelle Friedrich, et al.
Published: (2020-07-01)

Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
by: Madhusoodanan Mottamal, et al.
Published: (2015-03-01)

Ron knockdown and Ron monoclonal antibody IMC-RON8 sensitize pancreatic cancer to histone deacetylase inhibitors (HDACi).
by: Yi Zou, et al.
Published: (2013-01-01)

Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
by: Flávia Alves Verza, et al.
Published: (2020-06-01)

Antitheilerial Activity of the Anticancer Histone Deacetylase Inhibitors
by: Madhumanti Barman, et al.
Published: (2021-11-01)

Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure
by: Xiaodi Qiu, et al.
Published: (2019-02-01)

Cellular modulation and HIV reactivation in response to serial treatment of latently HIV infected CD4 T cells with histone deacetylase inhibitors (HDACi)
by: J. Maxwell, et al.
Published: (2019-07-01)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01)

Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors
by: Qing-Yu Xu, et al.
Published: (2020-03-01)

Oxadiazole derivatives: Histone deacetylase inhibitors in anticancer therapy and drug discovery
by: Balaji Wamanrao Matore, et al.
Published: (2022-08-01)

Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020-08-01)

A transcriptomic dataset used to derive biomarkers of chemically induced histone deacetylase inhibition (HDACi) in human TK6 cells
by: Eunnara Cho, et al.
Published: (2021-06-01)

Synergistic Anticancer Effect of Glycolysis and Histone Deacetylases Inhibitors in a Glioblastoma Model
by: Beata Pająk, et al.
Published: (2021-11-01)

Histone Deacetylase Inhibitors as Multitarget-Directed Epi-Drugs in Blocking PI3K Oncogenic Signaling: A Polypharmacology Approach
by: Kasturi Ranganna, et al.
Published: (2020-11-01)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
by: Masumeh Sanaei, et al.
Published: (2019-01-01)

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
by: Petrillo Richard L, et al.
Published: (2010-02-01)

Histone deacetylase inhibitors in multiple myeloma
by: Sarah Deleu, et al.
Published: (2009-06-01)

The application of histone deacetylases inhibitors in glioblastoma
by: Rui Chen, et al.
Published: (2020-07-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01)

Antidepressant Actions of Histone Deacetylase Inhibitors
by: Haggarty, Stephen J., et al.
Published: (2010)

Medicinal chemistry of histone deacetylase inhibitors
by: Ružić Dušan, et al.
Published: (2021-01-01)

Improved Anticancer Activities of a New Pentafluorothio-Substituted Vorinostat-Type Histone Deacetylase Inhibitor
by: Nils Goehringer, et al.
Published: (2021-12-01)

The synergistic anticancer effect of the bromodomain inhibitor OTX015 and histone deacetylase 6 inhibitor WT-161 in osteosarcoma
by: Bo Yu, et al.
Published: (2022-02-01)

Attenuation of choroidal neovascularization by histone deacetylase inhibitor.
by: Nymph Chan, et al.
Published: (2015-01-01)

Histone Deacetylase Inhibitors from Marine Invertebrates
by: Claudio Luparello, et al.
Published: (2020-11-01)

Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
by: Ehab Ghazy, et al.
Published: (2022-01-01)

The Impact of Fluorination on the Design of Histone Deacetylase Inhibitors
by: Duong Tien Anh, et al.
Published: (2023-02-01)

Histone Deacetylase Inhibitors and Diabetic Kidney Disease
by: Mitchell J. Hadden, et al.
Published: (2018-09-01)

The effect of histone deacetylase inhibitors on AHSP expression.
by: Mohammad Ali Okhovat, et al.
Published: (2018-01-01)

Dual Inhibitors Targeting DNA and Histone Deacetylases
by: Chen Chen, et al.
Published: (2020-06-01)

Zinc binding groups for histone deacetylase inhibitors
by: Lei Zhang, et al.
Published: (2018-01-01)

Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitors
by: Manali Singha, et al.
Published: (2022-11-01)

797 Significant anti-tumor activity of HBI-8000, a class I histone deacetylase inhibitor (HDACi) in combination with nivolumab (NIVO) in anti-PD1 therapy-naïve advanced melanoma (TN-Mel)
by: Joseph Markowitz, et al.
Published: (2020-11-01)

Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
by: Kim Freese, et al.
Published: (2019-10-01)

Statins and Histone Deacetylase Inhibitors Affect Lamin A/C – Histone Deacetylase 2 Interaction in Human Cells
by: Elisabetta Mattioli, et al.
Published: (2019-01-01)

Synthesis and Biological Evaluation of Small Molecules as Potential Anticancer Multitarget Agents
by: Alberto Pla-López, et al.
Published: (2022-06-01)